Drug combinations and the bioavailability of rifampicin

Tuber Lung Dis. 1992 Aug;73(4):242-4. doi: 10.1016/0962-8479(92)90095-2.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Anti-Bacterial Agents*
  • Biological Availability
  • Drug Therapy, Combination / pharmacokinetics*
  • Humans
  • Rifampin / pharmacokinetics*
  • Tuberculosis / drug therapy

Substances

  • Anti-Bacterial Agents
  • Rifampin